Aardvark Therapeutics, Inc.
San Diego, CA · Founded 2017 · CIK 0001774857 · Biotech · Public
Small-molecule drugs that inhibit hunger to treat metabolic disorders
aardvarktherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $103M
- 3 Form D · May 2024
- 29 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 4 granted · 36 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $9,000,003 | |
| Private capital raised | Form D · SEC | $9,060,000 | |
| Private capital raised | Form D · SEC | $84,999,982 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1253 | B-TECH CONSULTING, LTD | — | — |
| 1254 | MIND BIOSCIENCES LLC | — | — |
| 1255 | TScan Therapeutics | — | $123M |
| 1256 | Aardvark Therapeutics, Inc. | — | $103M |
| 1257 | Satellite Biosciences, Inc. | — | $101M |
| 1258 | GPN THERAPEUTICS, INC. | — | — |
| 1259 | AYTU BIOSCIENCE, INC | — | $26M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jerel BanksDirector
- Jeffrey ChiDirector
- Zachary HornbyDirector
- Henry JiDirector
- Tien-Li LeeDirector · Executive Officer
- Bob ShinDirector
- Nelson SunExecutive Officer
- Victor TongDirector
Patents
- Pharmaceutical Formulations Containing Phenylbutyrate And Methods Thereofapplication
- Method for Treating SARS and Treating or Preventing ARDSgranted
- Isoflavonoid Compounds And Methods For The Treatment Of Cancergranted
- Isoflavonoid Compositions And Methods For The Treatment Of Cancergranted
- Abuse-Deterrent Pharmaceutical Composition with Aversion Propertiesapplication
- Oral Pharmaceutical Formulations of Bitter Compounds for Asthmagranted
- Monohydrate Salt of Denatonium Acetateapplication
- Liquid Resin Extended-Release Oral Naltrexone Formulation for Treating Autism-Related Disordersapplication
- Combination Of Bitter Receptor Agonist And Gut-signaling Compoundapplication
- Denatonium Salt For Use In Preventing, Preventing Progression And Treating Fatty Liver Diseasesapplication
- Monohydrate Salt of Denatonium Acetateapplication
- Pharmaceutical Composition for Treatment or Prevention of Multiple Inflammatory disordersapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.